Latest Insider Transactions at Edwards Lifesciences Corp (EW)
This section provides a real-time view of insider transactions for Edwards Lifesciences Corp (EW). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Edwards Lifesciences Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Edwards Lifesciences Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 07
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Payment of exercise price or tax liability
|
Direct |
428
-1.25%
|
$38,948
$91.75 P/Share
|
|
May 07
2021
|
Robert W.A. Sellers SVP, Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
133
-1.19%
|
$12,103
$91.75 P/Share
|
|
May 07
2021
|
Daveen Chopra CVP, TMTT |
SELL
Payment of exercise price or tax liability
|
Direct |
304
-1.76%
|
$27,664
$91.75 P/Share
|
|
May 07
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Payment of exercise price or tax liability
|
Direct |
604
-0.95%
|
$54,964
$91.75 P/Share
|
|
May 07
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Payment of exercise price or tax liability
|
Direct |
362
-0.35%
|
$32,942
$91.75 P/Share
|
|
May 07
2021
|
Scott B. Ullem CVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
538
-1.67%
|
$48,958
$91.75 P/Share
|
|
May 07
2021
|
Kieran Gallahue Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,433
+34.62%
|
-
|
|
May 07
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
6,350
-6.21%
|
$577,850
$91.87 P/Share
|
|
May 07
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
6,350
+5.85%
|
$133,350
$21.76 P/Share
|
|
May 07
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
3,389
-9.87%
|
$308,399
$91.87 P/Share
|
|
May 07
2021
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
3,389
+8.99%
|
$74,558
$22.29 P/Share
|
|
May 07
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
11,050
-9.01%
|
$1,016,600
$92.69 P/Share
|
|
May 07
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
11,050
+14.74%
|
$232,050
$21.76 P/Share
|
|
May 05
2021
|
Steven R Loranger Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,615
+5.01%
|
-
|
|
May 05
2021
|
Heisz Leslie Stone Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,615
+9.41%
|
-
|
|
May 05
2021
|
Martha H. Marsh Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,615
+8.9%
|
-
|
|
May 05
2021
|
Ramona Sequeira Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,615
+30.65%
|
-
|
|
May 05
2021
|
Nicholas J Valeriani Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,615
+4.03%
|
-
|
|
May 05
2021
|
Paul A Laviolette Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,615
+50.0%
|
-
|
|
May 05
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
30,000
+0.94%
|
-
|
|
May 05
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
35,550
-13.47%
|
$3,270,600
$92.62 P/Share
|
|
May 05
2021
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
30,000
-18.7%
|
-
|
|
May 05
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
65,550
+28.74%
|
$852,150
$13.98 P/Share
|
|
May 04
2021
|
Daveen Chopra CVP, TMTT |
BUY
Grant, award, or other acquisition
|
Direct |
3,225
+15.73%
|
-
|
|
May 04
2021
|
Catherine M. Szyman CVP, Critical Care |
BUY
Grant, award, or other acquisition
|
Direct |
3,975
+11.38%
|
-
|
|
May 04
2021
|
Scott B. Ullem CVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,100
+13.67%
|
-
|
|
May 04
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Grant, award, or other acquisition
|
Direct |
4,000
+7.04%
|
-
|
|
May 04
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
BUY
Grant, award, or other acquisition
|
Direct |
2,850
+1.96%
|
-
|
|
May 04
2021
|
Michael A Mussallem Director |
BUY
Grant, award, or other acquisition
|
Direct |
21,425
+15.32%
|
-
|
|
May 04
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Grant, award, or other acquisition
|
Direct |
2,475
+2.52%
|
-
|
|
May 04
2021
|
Larry L Wood Global President TAVR & Surg |
BUY
Grant, award, or other acquisition
|
Direct |
4,575
+1.23%
|
-
|
|
May 04
2021
|
Robert W.A. Sellers SVP, Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
1,340
+10.71%
|
-
|
|
Apr 27
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
114,205
+3.53%
|
-
|
|
Apr 27
2021
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
114,205
-54.07%
|
-
|
|
Apr 23
2021
|
Heisz Leslie Stone Director |
SELL
Open market or private sale
|
Direct |
6,707
-22.91%
|
$650,579
$97.52 P/Share
|
|
Apr 23
2021
|
Heisz Leslie Stone Director |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+25.46%
|
$350,000
$35.68 P/Share
|
|
Apr 23
2021
|
Robert W.A. Sellers SVP, Corporate Controller |
SELL
Open market or private sale
|
Indirect |
12,000
-37.03%
|
$1,164,000
$97.66 P/Share
|
|
Apr 22
2021
|
Catherine M. Szyman CVP, Critical Care |
SELL
Open market or private sale
|
Direct |
3,389
-11.16%
|
$318,566
$94.4 P/Share
|
|
Apr 22
2021
|
Catherine M. Szyman CVP, Critical Care |
BUY
Exercise of conversion of derivative security
|
Direct |
3,389
+10.04%
|
$74,558
$22.29 P/Share
|
|
Apr 12
2021
|
Larry L Wood Global President TAVR & Surg |
SELL
Open market or private sale
|
Direct |
7,830
-2.11%
|
$665,550
$85.84 P/Share
|
|
Apr 12
2021
|
Larry L Wood Global President TAVR & Surg |
BUY
Exercise of conversion of derivative security
|
Direct |
7,830
+2.06%
|
$274,050
$35.2 P/Share
|
|
Apr 09
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
SELL
Open market or private sale
|
Direct |
13,077
-21.12%
|
$1,098,468
$84.27 P/Share
|
|
Apr 09
2021
|
Donald E Bobo Jr CVP,Strategy/Corp Development |
BUY
Exercise of conversion of derivative security
|
Direct |
13,077
+17.44%
|
$170,001
$13.98 P/Share
|
|
Apr 08
2021
|
Huimin Wang CVP, Japan & Intercontinental |
SELL
Open market or private sale
|
Direct |
6,350
-6.36%
|
$533,400
$84.88 P/Share
|
|
Apr 08
2021
|
Huimin Wang CVP, Japan & Intercontinental |
BUY
Exercise of conversion of derivative security
|
Direct |
6,350
+5.98%
|
$133,350
$21.76 P/Share
|
|
Apr 08
2021
|
Michael A Mussallem Director |
BUY
Bona fide gift
|
Indirect |
30,000
+0.99%
|
-
|
|
Apr 08
2021
|
Michael A Mussallem Director |
SELL
Open market or private sale
|
Direct |
68,550
-24.5%
|
$5,758,200
$84.45 P/Share
|
|
Apr 08
2021
|
Michael A Mussallem Director |
SELL
Bona fide gift
|
Direct |
30,000
-9.68%
|
-
|
|
Apr 08
2021
|
Michael A Mussallem Director |
BUY
Exercise of conversion of derivative security
|
Direct |
98,550
+24.14%
|
$1,281,150
$13.98 P/Share
|
|
Apr 01
2021
|
Jean Luc M Lemercier CVP, EMEACLA and JAPAC |
SELL
Open market or private sale
|
Direct |
13,020
-8.53%
|
$1,080,660
$83.66 P/Share
|